Artículo
Acid-labile subunit (ALS) deficiency
Fecha de publicación:
02/2011
Editorial:
Elsevier
Revista:
Best Practice & Research Clinical Endocrinology & Metabolism
ISSN:
1521-690X
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
The acid-labile subunit (ALS) protein is crucial for maintaining the integrity of the circulating IGF/IGFBP system. In humans, complete ALS deficiency is characterized by severely reduced serum IGF-I and IGFBP-3 concentrations that is incongruent with the associated mild growth retardation (height SDS -2 to -3 SDS before and during puberty). Twenty-one patients have been described with ALS deficiency, representing 16 unique homozygous or compound heterozygous inactivating mutations of the IGFALS gene. Pubertal delay in boys and insulin insensitivity are common findings. In the assessment of a child with short stature ALS deficiency should be consider in those patients presenting: 1) a normal response to GH stimulation test, 2) low IGF-I levels associated with more profoundly reduced IGFBP-3 levels, 3) a mild growth retardation, apparently out of proportion to the degree of IGF-I and IGFBP-3 deficits, 4) lack of response to an IGF generation test and 5) insulin insensitivity.
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(CEDIE)
Articulos de CENTRO DE INVESTIGACIONES ENDOCRINOLOGICAS "DR. CESAR BERGADA"
Articulos de CENTRO DE INVESTIGACIONES ENDOCRINOLOGICAS "DR. CESAR BERGADA"
Citación
Domene, Horacio Mario; Hwa, Vivian; Jasper, Hector Guillermo; Rosenfeld, Ron G.; Acid-labile subunit (ALS) deficiency; Elsevier; Best Practice & Research Clinical Endocrinology & Metabolism; 25; 1; 2-2011; 101-113
Compartir
Altmétricas